GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker.

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July.

Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London ...

Haleon was formed in July 2019 through the merger of GlaxoSmithKline’s (GB:GSK) and Pfizer’s consumer healthcare businesses. Subsequently, in July 2022, GSK spun off Haleon as an independent ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...

Haleon is a global consumer health company based in the UK, focused on developing and marketing over-the-counter health products. The company was formed as a spin-off from GSK (GlaxoSmithKline ...

2022 was a year of big changes at pharmaceutical giant GSK, with a new moniker—a shortening of its former name, GlaxoSmithKline—and the spinoff of its consumer business, which now operates ...

One of its crowning achievements in the Yankee market was working as a bookrunner on the US leg of the bond financing that backed Haleon’s spinoff from UK drugmaker GlaxoSmithKline. Haleon’s inaugural ...

Ahsan Mehanti of Arif Habib Corporation said stocks hit an all-time high led by blue chip scrips on IMF calls for ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...